The U.S. Food and Drug Administration in less than a 15-month period has granted a new and updated 510 clearance for two patented technologies made by NICO Corporation that are used in a new approach for brain surgery. Most recently, NICO received a new clearance for specific neurosurgical indications on its patented Myriad automated tissue removal technology.